Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026
30 January 2026

Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026

Medical Digest & Congress Report

About

Professor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.

Video: https://medicaldigest.org/scientific-contents/interview:redefining-epithelial-driven-airway-inflammation-insights-clinical-experience-tezepelumab